James F List

Summary

Affiliation: Bristol-Myers Squibb
Country: USA

Publications

  1. ncbi Sodium-glucose cotransport inhibition with dapagliflozin in type 2 diabetes
    James F List
    Global Clinical Research, Bristol Myers Squibb, Princeton, New Jersey, USA
    Diabetes Care 32:650-7. 2009

Detail Information

Publications1

  1. ncbi Sodium-glucose cotransport inhibition with dapagliflozin in type 2 diabetes
    James F List
    Global Clinical Research, Bristol Myers Squibb, Princeton, New Jersey, USA
    Diabetes Care 32:650-7. 2009
    ..In this multiple-dose study we evaluated the safety and efficacy of dapagliflozin in type 2 diabetic patients...